SANSONNO, Domenico Ettore
 Distribuzione geografica
Continente #
NA - Nord America 9.771
EU - Europa 2.201
AS - Asia 1.072
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 13.052
Nazione #
US - Stati Uniti d'America 9.764
CN - Cina 857
SE - Svezia 635
UA - Ucraina 503
DE - Germania 379
FI - Finlandia 275
SG - Singapore 171
IT - Italia 164
GB - Regno Unito 130
IE - Irlanda 36
FR - Francia 30
IN - India 24
BE - Belgio 14
RO - Romania 8
CA - Canada 7
IR - Iran 7
PL - Polonia 6
RU - Federazione Russa 4
TR - Turchia 4
VN - Vietnam 4
AL - Albania 3
EU - Europa 3
HK - Hong Kong 3
NL - Olanda 3
AT - Austria 2
AU - Australia 2
CZ - Repubblica Ceca 2
BG - Bulgaria 1
BR - Brasile 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JP - Giappone 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
YE - Yemen 1
ZA - Sudafrica 1
Totale 13.052
Città #
Fairfield 1.235
Jacksonville 1.191
Chandler 1.071
Woodbridge 859
Ashburn 640
Houston 488
Seattle 481
Nyköping 461
Cambridge 430
Wilmington 421
Ann Arbor 322
Nanjing 261
Lawrence 255
Roxbury 253
Des Moines 174
Singapore 141
New York 127
Boardman 119
Beijing 109
Princeton 95
Inglewood 92
Shenyang 77
Nanchang 70
Hebei 64
Brooklyn 61
San Diego 56
Santa Clara 46
Tianjin 45
Grafing 44
Jiaxing 41
Changsha 37
Dublin 35
Bari 28
Dearborn 27
Los Angeles 26
Jinan 24
Helsinki 23
Pune 17
Ningbo 16
Norwalk 16
London 15
Paris 15
Brussels 14
San Francisco 13
Tappahannock 13
Guangzhou 12
San Mateo 11
Washington 10
Hefei 9
Zhengzhou 9
Indiana 8
Redwood City 8
Auburn Hills 7
Rome 7
Ardabil 6
Augusta 6
Hangzhou 6
Hounslow 6
Kilburn 6
Napoli 6
Taizhou 6
Leawood 5
Milan 5
Shanghai 5
Bologna 4
Dong Ket 4
Kunming 4
Lowicz 4
Monmouth Junction 4
Seelze 4
Toronto 4
Triggiano 4
Islington 3
Lucca 3
Rende 3
Simi Valley 3
Trieste 3
Yellow Springs 3
Yiwu 3
Acton 2
Boydton 2
Brampton 2
Bucharest 2
Casamassima 2
Charlotte 2
Falls Church 2
Florence 2
Fuzhou 2
Haikou 2
Hong Kong 2
Lecce 2
Marseille 2
Munich 2
Naples 2
Prescot 2
Qingdao 2
Selargius 2
Strasbourg 2
Taranto 2
Wuxi 2
Totale 10.281
Nome #
null 122
Recent patents relating to HCV molecules like putative targets for therapeutic intervention. 119
The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review 112
HCV-related cryoglobulinemic vasculitis: An overview 107
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 107
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 106
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 106
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial. 104
Validation of the classification criteria for cryoglobulinaemic vasculitis 103
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins 103
B CELLS AND HCV: AN INFECTION MODEL OF AUTOIMMUNITY 99
null 96
Antibodies to glutaraldehyde-polymerized human albumin (anti-pHSA) in viral hepatitis. 94
Anticorpi anti-GOR. Caratterizzazione di autoantigeni ed autoanticorpi. 94
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 94
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 92
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay 92
B-cell depletion in the treatment of mixed cryoglobulinemia. 89
B-Cell lymphomas associated with HCV infection 88
Activation-induced cytidine deaminase in B cells of hepatits C virus-related cryoglobulinaemic vasculitis 88
MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20 87
Hepatitis C virus-associated B-cell non-Hodgkin's lymphoma: clinical and therapeutic challenges 86
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases 86
HEPATITIS C VIRUS RNA AND CORE PROTEIN IN KIDNEY GLOMERULAR AND TUBULAR STRUCTURES ISOLATED WITH LASER CAPTURE MICRODISSECTION 86
FAILURE TO DETECT HEPATITIS C VIRUS (HCV) GENOME BY POLYMERASE CHAIN REACTION IN HUMAN ANTI-HCV-POSITIVE INTRAVENOUS IMMUNOGLOBULINS 85
A RAPID DIRECT MICROWAVE IRRADIATION TECHNIQUE FOR DEMONSTRATING HEPATITIS-C VIRUS-ASSOCIATED C100 PROTEIN IN FORMALIN-FIXED LIVER-TISSUE 85
In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma 84
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association 84
Role of B-cell attracting chemokine-1 in HCV-related cryoglobulinemic vasculitis 83
Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection 83
INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS 83
Hepatitis A virus and non-A, non-B virus superinfections in HBsAg chronic carriers. 82
Thymic stromal lymphopoietin in hepatitis C virus-related cryoglobulinemic vasculitis: Gene expression level and protein distribution 82
Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. 81
ANTIBODIES TO HEPATITIS-C VIRUS IN NON-A, NON-B POST-TRANSFUSION AND CRYPTOGENETIC CHRONIC LIVER-DISEASE 79
Hepatitis C virus infection, cryoglobulinaemia, and beyond 79
An enzyme-linked immunosorbent assay for the detection of autoantibodies to albumin. 79
Barrett's esophagus and esophageal cancer: An overview. 79
HCV-ASSOCIATED B CELL CLONALITIES IN THE LIVER DO NOT CARRY THE T(14; 18) CHROMOSOMAL TRANSLOCATION 79
null 78
A METHOD FOR DETECTING SPECIFIC ANTI-C100 PROTEIN ANTIBODIES OF IGM ISOTYPE IN HEPATITIS-C VIRUS-INFECTION 78
Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents. 77
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 77
Immune-related disorders and extrahepatic diseases in chronic HCV infection. 76
MIXED CRYOGLOBULINEMIA: A MODEL OF VIRUS-RELATED DISEASE IN INTERNAL MEDICINE 76
IGM ANTI-C100-3 ANTIBODIES IN HEPATITIS-C VIRUS-INFECTION 74
Hepatitis C virus infection, lymphoproliferation and non-Hodgkin’s B cell lymphoma 74
Cytokines and HCV-Related Disorders. 74
Demonstration and distribution of HCV RNA sequences by in situ hybridization and HCV-related proteins by immunohistochemistry in the liver tissue of patients with chronic HCV infection 73
The higher prevalence of B-cell non-Hodgkin's lymphoma in HCV-positive patients with and without cryoglobulinemia 73
Molecular characterization of B-cell clonal expansions in the liver of chronically hepatitis C virus-infected patients 73
Ibridizzazione in situ non isotopica. Attualità e prospettive 72
Multidisciplinary approach for HCC patients: hepatology for the oncologists 72
Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations 71
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations 71
Role of the HLA class II - HCV-related disorders 71
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 71
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 71
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma 71
IMMUNOCHEMICAL AND BIOMOLECULAR STUDIES OF CIRCULATING IMMUNE COMPLEXES ISOLATED FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS C VIRUS INFECTION 70
Current and emerging therapeutic approaches in HCV-related mixed cryoglobulinemia 68
Correlation between hepatitis B virus deoxyribonucleic acid and receptors for polymerized human albumin in HBV chronic infection. 68
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 68
Receptor activity for polymerised human albumin in hepatitis B vaccine. 68
Detection of receptors for polymerised human albumin by immunoperoxidase and immunoadherence in liver tissue of HBsAg chronic carriers. 68
Cryoglobulinemic Vasculitis 67
Antiviral therapy in HCV-positive non-Hodgkin's lymphoma: pathogenetic implications 67
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 67
Endocrine manifestations of hepatitis C virus infection 66
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 66
C4d: a valuable marker of activation of the classical complement pathway in mixed cryoglobulinemia 66
HCV inhibits antigen processing and presentation and induces oxidative stress response in gastric mucosa 65
EXPRESSION AND DISTRIBUTION OF A HUMAN COLON-CARCINOMA-ASSOCIATED ANTIGEN IN NORMAL AND DISEASED LIVER-TISSUE 65
Preliminary classification criteria for the cryoglobulinaemic vasculitis 64
H. pylori infection and gastric cancer: state of the art (review). 64
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 63
Hepatitis C virus infection, mixed crioglobulinemia, and non-Hodgkin’s lymphoma: an emerging picture 62
null 61
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 61
DETECTION OF HEPATITIS C VIRUS (HCV) PROTEINS BY IMMUNOFLUORESCENCE AND HCV RNA GENOMIC SEQUENCES BY NON-ISOTOPIC IN SITU HYBRIDIZATION IN BONE MARROW AND PERIPHERAL BLOOD MONONUCLEAR CELLS OF CHRONICALLY HCV-INFECTED PATIENTS 60
PIRR therapy in HCV-related mixed cryoglobulinemia 59
B-cell frequency in HCV-related mixed cryoglobulinemia. 59
Potential neutralizing properties of anti-E2 antibodies in HCV-infected patients with lymphoproliferative disorders. 59
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. 59
MIXED CRYOGLOBULINEMIA SYNDROME AS AN ADDITIONAL AUTOIMMUNE DISORDER ASSOCIATED WITH RISK FOR LYMPHOMA DEVELOPMENT 59
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses 59
Mixed cryoglobulinemia as a model of systemic vasculitis 58
GRANULOCYTOPENIA AFTER COMBINED THERAPY WITH INTERFERON AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - EVIDENCE FOR A SYNERGISTIC HEMATOLOGIC TOXICITY 58
null 58
HEPATITIS C VIRUS WITHIN A MALIGNANT LYMPHOMA LESION IN THE COURSE OF TYPE II MIXED CRYOGLOBULINEMIA 58
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite (HCV) con e senza crioglobulinemia mista 57
Anti-C100 antibody of IgM isotype in hepatitis c virus-associated chronic liver disease 57
The emerging extrahepatic manifestations of hepatitis C virus infection in chronic hepatitis and mixed cryoglobulinemia 57
Demonstration of HBsAg as the antigen component in circulating immune complexes detected by peg-solid phase test. 57
The cryoglobulins: an overview 56
The Pivotal Role of C1qR in Mixed Cryoglobulinemia 55
B-cell clonal expansion in liver tissue of HCV+ patients 55
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects. 53
HIGH CIRCULATING CHEMOKINES (C-X-C MOTIF) LIGAND 9, AND (C-X-C MOTIF) LIGAND 11, IN HEPATITIS C-ASSOCIATED CRYOGLOBULINEMIA 53
Crioglobulinemia mista e infezione da HCV 53
Totale 7.573
Categoria #
all - tutte 55.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.537 0 0 81 258 381 185 401 265 431 150 308 77
2020/20212.136 252 171 233 67 265 82 191 90 277 285 133 90
2021/20221.545 43 226 7 86 58 117 58 99 76 74 300 401
2022/20232.708 417 190 139 307 291 424 16 310 489 10 60 55
2023/2024721 89 176 31 31 54 200 16 36 1 12 4 71
2024/2025355 33 43 279 0 0 0 0 0 0 0 0 0
Totale 13.187